EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

The Price of Precision: A Critical Review of Molecular Diagnostics in Glioma, From Guidelines to Global Disparities

Maria Guarnaccia iD, Sebastiano Cavallaro iD

Annals of Clinical and Translational Neurology · 2026-10 · 13 (10) · 1968-1977

DOI: 10.1002/acn3.70503 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 28.07.2026. Verfasst von Maria Guarnaccia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), Catania, Italy. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Practice Guidelines as Topic, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliomas have undergone a profound redefinition over the past decade, transitioning from morphology‐based entities to biologically coherent diseases defined by molecular alterations. The 2021 WHO Classification of Tumors of the Central Nervous System and its 2022 update formalize this shift, establishing integrated diagnosis as the global standard and identifying essential biomarkers—including IDH mutations, 1p/19q codeletion, ATRX loss, TP53 mutation, TERT promoter mutation, EGFR amplification, and +7/−10 cytogenetics—that shape prognosis, therapeutic decision‐making, and clinical trial eligibility. In this review, we synthesize the current molecular taxonomy of gliomas and compare recommendations from major international guidelines (WHO, NCCN, EANO) and the Italian Association of Neuro‐Oncology (AINO). Recognizing that contemporary practice employs a complementary, purpose‐driven array of diagnostic modalities—from immunohistochemistry and PCR‐based methods to next‐generation sequencing and DNA methylation profiling—we critically examine the profound global disparities that hinder implementation, focusing on economic constraints, infrastructural limitations, regulatory barriers, and workforce shortages. By integrating health‐economic evidence, we demonstrate that the societal and financial burden of non‐implementation far exceeds the investment required for molecular testing. We propose a tiered implementation framework in which clinically actionable information is obtainable for most glioma patients through accessible, cost‐effective technologies, with more resource‐intensive modalities reserved for specific clinical scenarios. Ensuring equitable access to integrated diagnostics, defined as the right test for the right clinical question, is essential not only for precision neuro‐oncology but also for global healthcare justice and scientific progress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsPractice Guidelines as TopicMolecular Diagnostic TechniquesPathology, MolecularHealthcare DisparitiesPrecision MedicineHumans

Stichwörter der Autor:innen

WHO Molecular Taxonomygliomasglobal disparitieshealth economicsintegrated diagnosisprecision medicinetiered diagnostics

Autor:innen und Institutionen

  • Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), Catania, Italy.

ORCID-Profile: Maria Guarnaccia, Sebastiano Cavallaro

Zitieren

APA

Guarnaccia, M., & Cavallaro, S. (2026). The Price of Precision: A Critical Review of Molecular Diagnostics in Glioma, From Guidelines to Global Disparities. Annals of Clinical and Translational Neurology, 13(10), 1968-1977. https://doi.org/10.1002/acn3.70503

Vancouver

Guarnaccia M, Cavallaro S. The Price of Precision: A Critical Review of Molecular Diagnostics in Glioma, From Guidelines to Global Disparities. Annals of Clinical and Translational Neurology. 2026;13(10):1968-1977. doi:10.1002/acn3.70503

BibTeX
@article{Guarnaccia2026,
  author = {Guarnaccia, Maria and Cavallaro, Sebastiano},
  title = {The Price of Precision: A Critical Review of Molecular Diagnostics in Glioma, From Guidelines to Global Disparities},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  volume = {13},
  number = {10},
  pages = {1968--1977},
  doi = {10.1002/acn3.70503}
}
Kostenlos starten →